Menu
Το καλάθι σας

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers
ΝΕΟ
Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers
180,00€
200,00€
Χωρίς ΦΠΑ: 169,81€

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers presents the latest advances in nanomaterials-based optical biosensor-enabled point-of-care testing (PoCT) devices for the rapid and accurate detection of cardiovascular disease (CVD) biomarkers. This book begins with the introduction of novel cardiovascular biomarkers and advances in point-of-care diagnostics. Subsequent chapters focus on the selection of bioreceptors and the overview of optical nanomaterials for nanobiosensors applications.A major focus is targeted on colorimetric detection, fluorescence, chemiluminescence, Localized Surface Plasmon Resonance, and Surface-Enhanced Raman Scattering-based optical nanobiosensor signaling readout techniques, which enable the detection of CVD biomarkers. Furthermore, this book explores emerging healthcare technologies for next-generation portable PoCT devices and recent advances in nanobiosensor techniques for the rapid detection of CVD biomarkers. One dedicated chapter explores the role of artificial intelligence in enhancing point-of-care diagnostics for CVDs, while another addresses critical regulatory challenges and safety considerations in translating nanomaterial-based biosensors into clinical practice.
- Provides a comprehensive overview of novel CVD biomarkers and advances in point-of-care diagnostic platforms
- Detailed exploration of bioreceptor selection and optical nanomaterials for enhancing the selectivity and sensitivity of nanobiosensors for point-of-care diagnostics
- Explores the design and advantages of colorimetric detection, fluorescence, chemiluminescence, LSPR, and SERS-based nanobiosensors techniques, which enable rapid and portable point-of-care testing of CVD biomarkers
- Integration of artificial intelligence to improve the precision, and efficiency of CVD diagnosis at the point-of-care
- Addresses key regulatory, safety, and clinical translation challenges that bridge the gap between laboratory innovations and real-world healthcare applications

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
Κακή Καλή
Ετικέτες: point-of-care , diagnostics , nanomaterials